The Utah Legislature鈥檚 $75 million allocation propels Huntsman Cancer Institute鈥檚 plan for a second comprehensive cancer center, advancing research and care. Discover how this initiative brings hope and progress.
Using a new platform, Jonathan Constance, PhD, researcher at Huntsman Cancer Institute, studies commonly prescribed medications in hopes of creating more effective treatments for pediatric cancer patients.
Researchers found tumors release a protein that triggers an immune attack on brain cells, which causes rapid cognitive decline. This discovery could lead to new treatments for this serious complication.
Huntsman Cancer Institute welcomes a distinguished leader celebrated for advocacy into a new, vital role. In her position, she will continue the important work of advancing cancer research and mentorship.
A new treatment for patients with head and neck cancers is available at Huntsman Cancer Institute. Single-port robotic surgery is a game-changer now accessible for people in the Mountain West.
Huntsman Cancer Institute's groundbreaking $20 million land donation from a developer for a new campus in Utah County promises expanded world-class care, breathtaking views, and reduced travel burden for patients.
From shrinking brain tumors to personalized therapies, our investigators are leading pioneering research, discovering breakthroughs in treatment, and promoting equity-driven care.
The Society of Huntsman Translational Scholars adds Umang Swami, MD, MS, and Matthew Covington, MD, to its cohort that advances cancer testing and treatments through financial support and collaboration.
Two visionary physician leaders take pivotal new roles to amplify innovation and patient-centric advancements in Huntsman Cancer Institute鈥檚 quest for a future free from cancer.
Thanks to funding from the National Cancer Institute, Kimberly Kaphingst, director of cancer communication research, and her team are exploring a new way to teach people about genetic testing options.
